-
Yale University: A combination of quercetal monotherapy and chemotherapy can effectively treat invasive endometrial cancer
Time of Update: 2020-07-18
corresponding author of the study entitled "randomized phase II trial of carboplatin – paclitaxel compared with carboplatin – paclitaxel – trastuzumab in advanced (stage III – IV) or recurrent urethane serous carcinomas that overexpress HER2 / neu (nct01367002): updated overall survival analysis" "This randomized, multi agency, phase 2 trial studied 58 women with uterine serous carcinoma (USC) whose tumors expressed high levels of HER2, which can cause a variety of cancers," Dr. Santin said.
-
January-April 2020 Furniture, home appliances, bicycles, plastic products industry operation
Time of Update: 2020-07-16
Furniture Production From January to April 2020, the national furniture manufacturing industry produced 239.758 million pieces, down 16.8% YoY in April, the country's furniture manufacturing industry
-
Rybelsus, the first and only ORAL GLP-1 agonisant, has been recognized again
Time of Update: 2020-07-13
Novo Nordisk's type 2 diabetes drug, the oral GLP-1 agonisant Rybelsus, has been approved for sale in Japan Japan's Ministry of Health, Labour (MHLW) approval was approved by the FDA in October la
-
Improving motor function in children with muscular dystrophy Gene therapy phase 1/2 clinical results
Time of Update: 2020-07-09
Sarepta Therapeutics, which specializes in the development of rare disease therapies, announced that its research type 2E limb-belt muscular dystrophy (LGMD2E) gene therapy SRP-9003 has received posit
-
New case of mad cow disease found at dairy farm in western Canada
Time of Update: 2020-07-06
The Canadian Food and Quarantine Agency said in a statement on the 18th a new case of mad cow disease found at a dairy farm in Alberta, western Canada This is the 11th case of mad cow disease dete
-
Japan's men's cosmetics and beauty market is heating up
Time of Update: 2020-07-05
, japan's men's cosmetics and beauty market has been heating up in recent years as traditional attitudes have changed, and growth is expected to continue in the coming years, Kyodo news agency rep
-
Domestic second HPV vaccine accepted and expected to be available within the next year or two
Time of Update: 2020-06-26
Pharmaceutical Network Industry Dynamic : Following the launch of the second-priceD HPV vaccine by Wantai Bio, the development of the second HPV vaccine in China has also achieved a breakthrough On
-
Antibody drug conjugate ILUMYA (tildrakizumab-asmn) treatment of moderate-severe plaqueized psoriasis: good long-term safety effectiveness
Time of Update: 2020-06-16
The pharmaceutical company Sun today announced that it will present the long-term use and cost-benefit analysis of ILUMYATM (tildrakizumab-asmn, targeting IL-23) for the treatment of moderate to seve
-
Global cell therapy up to 1483 kinds of Chinese research and development tests follow the United States
Time of Update: 2020-06-15
Texts In the latest day, Nature Reviews Drug Discovery 2020 report shows that the field of cell immunotherapy continues to expand, with 1,483 active therapies in the global cancer cell therapy pipel
-
J Rheumatol: Association between increased waist circumference in adult knee osteoarthritis patients and reduced risk of physical function
Time of Update: 2020-05-29
The study looked at the association between eight-year changes in waist circumference (WC) in adult knee osteoarthritis (OA) patients and high-risk populations and the risk of decreased bodily func
-
Media Exposure: 3 Companies' Troubles Are At Risk
Time of Update: 2020-05-13
"Wearable" performance is depressed Jiu'an Medical transformation is difficult May 21, Jiu'an Medical (002432) at one point to 38.20 yuan per share, with a total market value of 14.173 billion yua
-
Phase IV clinical application of Yikai tablet (pancreatic kininogenase enteric coated tablet), a key product of Qianhong pharmaceutical
Time of Update: 2020-04-03
Haitao, marketing director of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd., said in the investigation that the company's main product, Yikai tablet (Pancreatic Kallidinogenase enteric coate
-
Dragon-Based Lilian will showcase TiO2 pigments for high-performance plastics in K2019
Time of Update: 2020-03-03
Lomon Billions will promote its high-performance titanium dioxide (TiO2) pigmentfor plastics at the K2019 exhibition in Dusseldorf, Germany This is the first time the Chinese company has its own boo
-
The products of 29 pharmaceutical companies "going abroad" are bright and bright
Time of Update: 2020-01-19
Original title: 29 pharmaceutical companies, 96 andas!
Want to disrupt the market of more than 30 billion
-
Clinical research and development of children's medicines, classic prescriptions, and traditional Chinese medicines will accept real-world data
Time of Update: 2020-01-09
On January 7, the State Food and Drug Administration officially released the guiding principles of real world evidence supporting drug development and review (Trial) Among them, it mainly includes six
